Short Interest in Endonovo Therapeutics, Inc. (OTCMKTS:ENDV) Grows By 300.0%

Endonovo Therapeutics, Inc. (OTCMKTS:ENDV) saw a significant growth in short interest during the month of March. As of March 15th, there was short interest totalling 400,000 shares, a growth of 300.0% from the February 28th total of 100,000 shares. Based on an average daily volume of 23,757,600 shares, the days-to-cover ratio is currently 0.0 days. Currently, 0.0% of the company’s shares are short sold.

Endonovo Therapeutics Trading Down 33.3 %

Shares of ENDV stock traded down $0.00 during midday trading on Thursday, reaching $0.00. 97,249,932 shares of the stock were exchanged, compared to its average volume of 32,224,309. Endonovo Therapeutics has a 1 year low of $0.00 and a 1 year high of $0.01.

Endonovo Therapeutics Company Profile

Endonovo Therapeutics, Inc, a biotechnology company, develops, manufactures, and distributes non-invasive Electroceutical medical devices for regenerative medicine. The company offers SofPulse, a non-invasive Electroceutical therapeutic device for the palliative treatment of soft tissue injuries, chronic wounds, and post-operative pain and edema.